14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AQSZF
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

FAQ

What is the symbol for Aequus Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Aequus Pharmaceuticals Inc. is AQSZF and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell Aequus Pharmaceuticals Inc. Stock?
Aequus Pharmaceuticals Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Aequus Pharmaceuticals Inc. Stock?
Aequus Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aequus Pharmaceuticals Inc. Stock.

What's the current price of Aequus Pharmaceuticals Inc. Stock?
As of the end of day on the May 01, 2024, the price of an Aequus Pharmaceuticals Inc. (AQSZF) share was $0.0094.

What is the 52-week high and low for Aequus Pharmaceuticals Inc. Stock?
The 52-week high for Aequus Pharmaceuticals Inc. Stock is $0.0400 and the 52-week low is $0.0079.

What is the market capitalization of Aequus Pharmaceuticals Inc. Stock?
As of the May 01, 2024, the market capitalization of Aequus Pharmaceuticals Inc. is 1.25M.

When is the next earnings date for Aequus Pharmaceuticals Inc.?
The upcoming earnings date for Aequus Pharmaceuticals Inc. is Jul 24, 2024.
Click to get the best stock tips daily for free!

About Aequus Pharmaceuticals Inc.

Aequus Pharmaceuticals. Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. It focuses on various therapeutic areas, including neurology, ophthalmology, and transplantation. The company markets Vistitan, an ophthalmology product to reduce elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Tacrolimus IR, an immunosuppressant for the treatment and prevention of acute rejectio... AQSZF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT